Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs. Bolus Infusion for Peripheral Nerve Blocks
NCT03230565Phase 4Recruiting
- Sponsor
- Stanford University
- Start
- Jun 2018
- Primary completion
- Dec 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Stanford University. Started Jun 2018; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03230565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230565.